Cytogenetic Methods and Diagnosis
Cytogenetic methods are the laboratory techniques used to visualise and interpret the number and structure of chromosomes, and to detect the gains, losses, and rearrangements that underlie constitutional and acquired genetic disease. This area orients the reader across the major diagnostic approaches, from whole-chromosome karyotyping through targeted fluorescence probes to genome-wide microarray, that together form the diagnostic toolkit of clinical cytogenetics.
Definition
Cytogenetic diagnosis is the laboratory analysis of chromosomes and submicroscopic copy-number changes to identify numerical and structural abnormalities, using a graded set of techniques that differ in resolution, target specificity, and the type of abnormality each can detect.
Scope
The area covers the principles, resolution, and complementary roles of the principal cytogenetic methods used in diagnosis: metaphase karyotyping with chromosome banding, fluorescence in situ hybridization (FISH), and chromosomal microarray with comparative genomic hybridization. It frames these as methodological topics and as a reference to how chromosomal findings are generated and reported, not as clinical management guidance.
Sub-topics
Core questions
- Which abnormalities can each cytogenetic method detect, and at what resolution?
- How do whole-genome (karyotype, microarray) and targeted (FISH) approaches complement one another?
- When does a balanced rearrangement require a method that microarray cannot detect?
- How are cytogenetic findings standardised and reported across laboratories?
Key concepts
- Resolution and detection limit of a technique
- Numerical versus structural chromosome abnormality
- Balanced versus unbalanced rearrangement
- Copy-number variation (CNV)
- Whole-genome versus targeted analysis
- International System for Human Cytogenomic Nomenclature (ISCN) reporting
- First-tier diagnostic testing
Mechanisms
The methods form a resolution ladder. Metaphase karyotyping with banding visualises the whole genome at the level of whole chromosomes and large structural changes (typically several megabases), and uniquely reveals balanced rearrangements and ploidy. FISH applies labelled DNA probes to detect or count specific loci in metaphase or interphase cells, trading genome-wide coverage for high target specificity. Chromosomal microarray and comparative genomic hybridization compare a test genome against a reference to map copy-number gains and losses across the genome at far higher resolution than banding, at the cost of being unable to detect balanced rearrangements or low-level mosaicism. Choosing among them, or combining them, depends on the clinical question and the kind of abnormality suspected.
Clinical relevance
Cytogenetic testing supports the evaluation of congenital anomalies, developmental disability, recurrent pregnancy loss, and many cancers, and its results are central to genetic counselling. Consensus guidance has positioned chromosomal microarray as a first-tier test for unexplained developmental disability or congenital anomalies, while karyotyping and FISH retain defined roles. This area describes how such evidence is generated and reported; it is not a basis for individual diagnostic or treatment decisions.
Evidence & guidelines
Professional consensus, including the international statement by Miller and colleagues (2010), has codified the relative roles of these methods and recommended chromosomal microarray as a first-tier test in defined clinical settings. Standardised reporting follows the International System for Human Cytogenomic Nomenclature.
History
Human cytogenetics began once the correct human chromosome number (46) was established in 1956 and banding techniques in the late 1960s and early 1970s made individual chromosomes identifiable. Fluorescence in situ hybridization in the 1980s added locus-specific resolution, and comparative genomic hybridization and microarray from the 1990s extended analysis to genome-wide copy-number detection, progressively merging classical cytogenetics with molecular biology.
Key figures
- Torbjörn Caspersson
- Daniel Pinkel
- Anne Kallioniemi
- Michael Speicher
- Nigel Carter
Related topics
Seminal works
- speicher-carter-2005
- miller-2010
Frequently asked questions
- Why are there several cytogenetic methods rather than one?
- Each method detects different kinds of abnormality at different resolutions: karyotyping sees whole-genome and balanced rearrangements, FISH targets specific loci with high sensitivity, and microarray maps copy-number changes genome-wide at high resolution. They are complementary rather than interchangeable.
- Can chromosomal microarray replace the karyotype entirely?
- No. Microarray offers much higher resolution for copy-number gains and losses, but it cannot detect balanced rearrangements (such as balanced translocations or inversions) or some forms of low-level mosaicism, which a karyotype can reveal.